Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
System and method of automatic piloting for in-flight refuelling of aircraft, and aircraft comprising said system
Composite high reflectivity layer
Active pellet without chemical additives
Reception circuit and signal reception method
Method and arrangement for controlling semiconductor component
Discovery, analysis, and visualization of dependencies
Apparatus for performing timer management regarding a system timer scheduler service, and associated method
  Randomly Featured Patents
Installation for coating products with a pulverulent material
Driving/electric-power generating system for vehicle
Optical tracking system using variable focal length lens
System and method for machine-assisted election auditing
Transgenic fish and uses thereof
Granulated bleaching activators and their preparation
Fluid delivery system and related methods of use
Electrified emergency exit device having an accessible hold off lock
Semiconductor device and boot method for the same
Temperature-sensitive indicator